{{Rsnum
|rsid=4730775
|Gene=WNT2
|Chromosome=7
|position=117277064
|Orientation=plus
|GMAF=0.3545
|Gene_s=WNT2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 34.5 | 42.5 | 23.0
| HCB | 67.9 | 27.7 | 4.4
| JPT | 68.1 | 23.9 | 8.0
| YRI | 46.9 | 45.6 | 7.5
| ASW | 40.4 | 49.1 | 10.5
| CHB | 67.9 | 27.7 | 4.4
| CHD | 55.0 | 36.7 | 8.3
| GIH | 54.5 | 39.6 | 5.9
| LWK | 58.2 | 36.4 | 5.5
| MEX | 43.1 | 43.1 | 13.8
| MKK | 59.0 | 32.7 | 8.3
| TSI | 21.6 | 46.1 | 32.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21732829
|Trait=None
|Title=Wnt signaling and Dupuytren's disease.
|RiskAllele=
|Pval=3E-8
|OR=1.2000
|ORtxt=None
}}

{{PMID Auto
|PMID=20492734
|Title=No association between polymorphisms of WNT2 and schizophrenia in a Korean population.
|OA=1
}}

{{PMID Auto
|PMID=20626912
|Title=Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in a Korean population.
|OA=1
}}

{{PMID Auto
|PMID=22489561
|Title=WNT2 Locus Is Involved in Genetic Susceptibility of Peyronie's Disease.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}